Archive for the ‘Emergent BioSolutions’ Category

Emergent BioSolutions to Release Fourth Quarter and Full Year 2011 Financial Results and Conduct a Conference Call on March 8, 2012

ROCKVILLE, Md.–(BUSINESS WIRE)–Jan. 30, 2012– Emergent BioSolutions Inc. (NYSE: EBS) announced today that it will report financial results for the fourth quarter and full year 2011 on Thursday, March 8, 2012, after market close.
Company management will host a conference call at 5:00 pm Eastern on March 8, 2012 to discuss the financial results for the [...]

Fuad El-Hibri and the TAKREEM Achievement Awards

TAKREEM was created as a venue in which to recognize outstanding accomplishments of Arab men and women. Through the TAKREEM Achievement Awards excellence in the Arab world is identified and highlighted, communicating to the level of experience and expertise among organizations and individuals present among Arabs living throughout the world.
Awards are given in ten categories including [...]

Fuad El-Hibri on Arabian Business Power 500

ArabianBusiness.com focuses on the business of Arabs around the globe. The site’s Power 500 list identifies the world’s most influential Arabs, chronicling their achievements; a veritable who’s who among the most successful Arabs in the world. Men and women on the list contribute to a variety of fields including banking and finance, construction, media, [...]

Fuad El-Hibri Announces Emergent BioSolutionsAward to Supply BioThrax Anthrax Vaccine to U.S. Government

Fuad El-Hibri, chairman and chief executive officer of Emergent BioSolutions Inc.,(NYSE: EBS) announced that, in response to solicitation RFP-2011-N-13414, it has received an award to supply the U.S. government with 44.75 million doses of BioThrax(R) (Anthrax Vaccine Adsorbed) over a period of five years for a total value of up to $1.25 billion. BioThrax is [...]

FUAD EL-HIBRI TO AWARD 2011 EL-HIBRI PEACE EDUCATION PRIZE TO GENE SHARP

The El-Hibri Charitable Foundation has announced that internationally acclaimed author and educator Gene Sharp has been selected as the 2011 recipient of the El-Hibri Peace Education Prize. In 2009 Dr. Sharp was nominated for the Nobel Peace Prize.
“Gene Sharp has dedicated his life to researching and teaching the strategic uses of nonviolent struggle against the [...]

Emergent BioSolutions to Present at Jefferies 2011 Global Healthcare Conference in London

Emergent BioSolutions Inc. (NYSE: EBS) will be webcasting its presentation at the Jefferies 2011 Global Healthcare Conference in London on Tuesday, September 27, 2011 at 3:40 PM BST. During the presentation, a member of the company’s management team will provide a corporate overview, which may include a discussion of the company’s business activities and financial [...]

Fuad El-Hibri Interviewed by Ricardo Karam

Fuad El-Hibri was interviewed a few months ago by Ricardo Karam. This interview was aired in the 2011 season on the Ricardo Karam’sShow, which focuses on successful people from the Arab community. Ricardo Karam is a well known talk show host who has interviewed many high profile people, such as Celine Dion, Charles Aznavour, Paolo [...]

Emergent Announces Initiation of a Phase 1b/2 Study of TRU-016 in Combination with Rituximab and Bendamustine in Subjects with Relapsed – Indolent Lymphoma

ROCKVILLE, Md., Aug 17, 2011 –
Emergent BioSolutions Inc. (NYSE:EBS) today announced the initiation of a Phase 1b/2 study (16011) of TRU-016 in combination with rituximab and bendamustine for patients with relapsed indolent non-Hodgkin’s B-cell lymphomas, including follicular lymphoma, small lymphocytic lymphoma and marginal zone lymphoma. TRU-016 is a CD37-directed Small Modular ImmunoPharmaceutical(TM) protein therapeutic in development for [...]

Fuad El-Hibri and the Heifetz International Music Institute

The Heifetz International Music Institute was established by Daniel Heifetz and is based in Ellicott City, Maryland. The institute also holds a six-week long summer festival program to train young musicians,  held at Brewster Academy in New Hampshire.
The founder, violinist Daniel Heifetz, has played with many world-renowned orchestras and has taught master classes as well as [...]

Singapore Health Sciences Authority Approves Emergent BioSolutions Anthrax Vaccine, BioThrax

ROCKVILLE, Md., — Emergent BioSolutions Inc. (NYSE:EBS) announced on June 23rdthat the Singapore Health Sciences Authority (HSA) has approved Emergent’s product license application for the marketing and sale of BioThrax(R) (Anthrax Vaccine Adsorbed) in Singapore. BioThrax is the only vaccine licensed by the U.S. Food and Drug Administration (FDA) to protect against anthrax infection.
“Emergent is [...]